Opinion

EDITORIAL

JAMA Oncology—The Year in Review, 2019 Mary L. (Nora) Disis, MD

JAMA Oncology had a very active year in 2019. The journal’s receive the JAMA Oncology electronic table of contents by of 22.4 places it as one of the highest-ranking email, you can sign up at http://www.jamaoncology.com.We oncology journals. I thank our authors, peer reviewers, and are proud to continue offering the most innovative, provoca- readers for the significant contributions made to the journal tive, and timely research for scientists, clinicians, and train- this past year. The editorial ees in the field of oncology worldwide. I encourage readers

Related article board, our JAMA Oncology to stay involved with the journal by submitting Letters to the editors, and I are honored to Editor and offering recommendations for new topics that have the opportunity to serve the oncology community by you would like to see covered in future issues. Your sugges- offering original, innovative, and timely scientific content tions make this interdisciplinary oncology journal dynamic that has a direct impact on researchers, clinicians, and the and current. patients we serve. We have truly enjoyed being involved in JAMA Oncology’s Choosing manuscripts for the journal was rewarding continued success this year and look forward to the year ahead. but challenging. We received a total of 2980 manuscript sub- We could not have done it without you. I invite all of our missions in 2019. These submissions to JAMA Oncology readers to follow us on Twitter @JAMAOnc or friend JAMA included 1743 Original Investigations, 66 Clinical Trial Oncology on Facebook. We will keep you up to date on the most reports, 66 Meta-analyses, and 70 Reviews. In 2019, we important discoveries influencing cancer care. published 419 total articles, including 119 Original Investiga- tions, 31 Research Letters, 32 Viewpoints, 10 Reviews, and Table. JAMA Oncology Statistics for 2019

5 Special Communications. I thank our authors for choosing Characteristica Result JAMA Oncology. The quality of their articles is reflected in the Manuscript data more than 2.6 million views and downloads of JAMA Oncology All manuscripts received 2980 articles last year. Research manuscripts receivedb 2393 In 2019, the overall acceptance rate was 13%. Our accep- Acceptance rate, % tance rate was 6% for Original Investigations, 35% for Clinical Trials reports, and 39% for Meta-analyses. We accepted 13% Overall 13 of Review articles, 11% of submitted Research Letters, 30% of Research 6 Viewpoints, and 16% of Clinical Challenges. JAMA Oncology Peer reviewer turnaround, median, d 14 is indexed in PubMed/MEDLINE, Citation Index Receipt to first decision without , 2 Expanded, , and other databases. More detailed statis- median, d tics about our content are displayed in the Table.1-3 Receipt to first decision with peer review, 39 median, d We are also very grateful to our global consortium of Acceptance to publication, median, d 92 peer reviewers who contributed to the journal this year.4 Receipt to publication, median, d 138 I am pleased to acknowledge their contribution to JAMA 2018 Journal impact factor 22.4 Oncology by publishing the names of the more than 700 experts who completed a manuscript review in 2019. This Information dissemination data group of renowned laboratory, clinical, quantitative, and sta- Recipients of electronic table of contents >49 000 per week tistical scientists provided comprehensive reviews of the Full-text/PDF downloads per year >2.5 million submitted manuscripts in a median of just 14 days. The abil- Twitter and Facebook followers >55 000 ity to rapidly review and return a decision on our submis- sions within a couple of weeks ensures that authors receive Top 3 articles by Altmetric score 1 efficient service in reviewing their work and that those 1. Garcia-Murillas et al, Assessment of Molecular 821 Relapse Detection in Early-Stage Breast Cancer important findings are available to the oncology community 2. Yang et al,2 Association of Dietary Fiber 651 as quickly as possible. We would not be able to provide this and Yogurt Consumption With Lung Cancer Risk: service without our expert peer reviewers and their commit- A Pooled Analysis 3 ment to providing prompt and high-quality reviews for the 3. Liu et al, Association of Obesity With Risk 581 of Early-Onset Colorectal Cancer Among Women journal. We thank you! a Data based on all manuscripts submitted, including research, review and Finally, I thank our readers. We provide our electronic education, opinion, and letters. table of contents of newly published material each week by b Includes Original Investigations, Brief Reports, and Research Letters. email to more than 49 000 readers. If you currently do not

jamaoncology.com (Reprinted) JAMA Oncology May 2020 Volume 6, Number 5 639

© 2020 American Medical Association. All rights reserved.

Downloaded From: https://jamanetwork.com/ on 09/30/2021 Opinion Editorial

ARTICLE INFORMATION Conflict of Interest Disclosures: None reported. cancer risk: a pooled analysis. JAMA Oncol. Published Author Affiliations: Fred Hutchinson Cancer online October 24, 2019. doi:10.1001/jamaoncol. Research Center, University of Washington, Seattle; REFERENCES 2019.4107 Editor, JAMA Oncology. 1. Garcia-Murillas I, Chopra N, Comino-Méndez I, 3. Liu P-H, Wu K, Ng K, et al. Association of obesity Corresponding Author: Mary L. (Nora) Disis, MD, et al. Assessment of molecular relapse detection with risk of early-onset colorectal cancer among Fred Hutchinson Cancer Research Center, in early-stage breast cancer. JAMA Oncol. 2019;5 women. JAMA Oncol. 2019;5(1):37-44. doi:10.1001/ University of Washington, 850 Republican St, (10):1473-1478. doi:10.1001/jamaoncol.2019. jamaoncol.2018.4280 Brotman 221, Box 358050, Seattle, WA 1838 4. JAMA Oncology peer reviewers in 2019. JAMA 98195-8050 ([email protected]). 2. Yang JJ, Yu D, Xiang Y-B, et al. Association of Oncol. Published online March 26, 2020. doi:10.1001/ Published Online: March 26, 2020. dietary fiber and yogurt consumption with lung jamaoncol.2020.0100 doi:10.1001/jamaoncol.2020.0134

640 JAMA Oncology May 2020 Volume 6, Number 5 (Reprinted) jamaoncology.com

© 2020 American Medical Association. All rights reserved.

Downloaded From: https://jamanetwork.com/ on 09/30/2021